These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8746659)
1. Drug interaction and pharmacological considerations during anti-infective therapy in cancer patients. Petitjean O; Nicolas P; Tod M Cancer Treat Res; 1995; 79():255-80. PubMed ID: 8746659 [No Abstract] [Full Text] [Related]
2. Drug interactions with quinolones. Lode H Rev Infect Dis; 1988; 10 Suppl 1():S132-6. PubMed ID: 3279488 [TBL] [Abstract][Full Text] [Related]
3. Absorption interactions with fluoroquinolones. 1995 update. Lomaestro BM; Bailie GR Drug Saf; 1995 May; 12(5):314-33. PubMed ID: 7669261 [TBL] [Abstract][Full Text] [Related]
4. Antacid interaction with new quinolones: dose regimen recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations. Miyata K; Ohtani H; Tsujimoto M; Sawada Y Int J Clin Pharmacol Ther; 2007 Jan; 45(1):63-70. PubMed ID: 17256452 [TBL] [Abstract][Full Text] [Related]
5. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management. Radandt JM; Marchbanks CR; Dudley MN Clin Infect Dis; 1992 Jan; 14(1):272-84. PubMed ID: 1571442 [TBL] [Abstract][Full Text] [Related]
6. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Müller M; dela Peña A; Derendorf H Antimicrob Agents Chemother; 2004 May; 48(5):1441-53. PubMed ID: 15105091 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. Stein GE Clin Infect Dis; 1996 Dec; 23 Suppl 1():S19-24. PubMed ID: 8953102 [TBL] [Abstract][Full Text] [Related]
8. Cefdinir--a new oral cephalosporin. Med Lett Drugs Ther; 1998 Aug; 40(1034):85-7. PubMed ID: 9731242 [No Abstract] [Full Text] [Related]
9. Fluoroquinolones: interaction profile during enteral absorption. Deppermann KM; Lode H Drugs; 1993; 45 Suppl 3():65-72. PubMed ID: 7689454 [TBL] [Abstract][Full Text] [Related]
11. Interactions of anti-infectives: a review. Barcia E; Negro S Chemotherapy; 2005 Jul; 51(4):197-9. PubMed ID: 16006766 [TBL] [Abstract][Full Text] [Related]
12. Quinolone interactions with divalent or trivalent cations: have you checked the medication administration report lately? Redmond AM; Norwood JM; Amarshi N; Self T South Med J; 2003 Sep; 96(9):941-2. PubMed ID: 14513999 [No Abstract] [Full Text] [Related]
15. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials. Aminimanizani A; Beringer P; Jelliffe R Clin Pharmacokinet; 2001; 40(3):169-87. PubMed ID: 11327197 [TBL] [Abstract][Full Text] [Related]
16. Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions. Borcherding SM; Stevens R; Nicholas RA; Corley CR; Self T J Fam Pract; 1996 Jan; 42(1):69-78. PubMed ID: 8537808 [TBL] [Abstract][Full Text] [Related]
17. Quinolones: which generation for which microbe? Lee MK; Kanatani MS West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165 [No Abstract] [Full Text] [Related]
18. [Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?]. Hooymans PM; Merkus FW Ned Tijdschr Geneeskd; 1986 Mar; 130(9):395-9. PubMed ID: 2870436 [No Abstract] [Full Text] [Related]
19. Antimicrobial drug interactions in the critically ill patients. Pereira JM; Paiva JA Curr Clin Pharmacol; 2013 Feb; 8(1):25-38. PubMed ID: 22946870 [TBL] [Abstract][Full Text] [Related]